VEGFC/VEGFR3 axis mediates TGFβ1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells.

VEGFC/VEGFR3 axis mediates TGFβ1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells.
复制标题

DOI:
10.1371/journal.pone.0200452
复制
发表时间:
2018
期刊:
影响因子:
3.7
通讯作者:
Huang Y
Huang Y
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Duan L;Ye L;Zhuang L;Zou X;Liu S;Zhang Y;Zhang L;Jin C;Huang Y

文献摘要

参考文献

被引文献

相似文献

In the tumor progression, transforming growth factor β1 (TGFβ1) plays a critical role in tumorigenesis as well as metastasis. It is known that high plasma level of TGFβ1 in patients with advanced non-small cell lung cancer (NSCLC) is correlated with poor prognostics. In addition, the generation of cancer stem-like cells is associated with metastasis, drug resistance, and tumor recurrence, which also lead to poor outcomes in NSCLC patients. However, it remains unclear how TGFβ1 promotes NSCLC cells to acquire stem-like properties and accelerate tumor metastasis. In our study, we found that short term TGFβ1 treatment resulted in a significant epithelial-mesenchymal transition (EMT) morphological change in TGFβ1–sensitive NSCLC cells but not in insensitive cells. Western blotting confirmed increased Vimentin and reduced E-Cadherin protein expression after TGFβ1 treatment in A549, NCI-H1993, and NCI-H358 cells. TGFβ1 incubation dramatically decreased in vitro cell proliferation and increased cell invasion in TGFβ1–sensitive NSCLC cells but not in NCI-H1975, NCI-H1650, and HCC827 cells. Moreover, TGFβ1 was able to enhance the mRNA expression of Oct4, Nanog and Sox2 and drastically increased anchorage-independent colony formation in TGFβ1–sensitive NSCLC cells, suggesting the acquisition of cancer stem-like properties. Interestingly, we found that vascular endothelial growth factor receptor 3 (VEGFR3) mRNA expression was significantly elevated in TGFβ1–sensitive NSCLC cells compared to insensitive cells. And TGFβ1 was capable of inducing VEGF-C gene expression. Pharmacological blocking TGFβ type I receptor kinase (ALK5) significantly inhibited TGFβ1-induced VEGF-C expression. Silencing of ALK5 by siRNA also dramatically reduced TGFβ1-induced VEGF-C expression in TGFβ1–sensitive NSCLC cells. Therefore, TGFβ1 contributes for NSCLC metastasis through promoting EMT, generation of high invasive cancer cells with stem-like properties, and increasing VEGF-C expression. Blocking TGFβ pathway is a potential therapeutic target in human non-small cell lung cancer.
DOI: 10.1248/bpb.34.1785
发表时间: 2011-12-01
影响因子: 2
作者:
Takahashi, Satoru
通讯作者: Takahashi, Satoru
DOI: 10.3390/jcm6010007
发表时间: 2017-01-06
影响因子: 3.9
作者:
Costanza B;Umelo IA;Bellier J;Castronovo V;Turtoi A
通讯作者: Turtoi A
DOI: 10.1158/0008-5472.can-06-1392
发表时间: 2006-08-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Hoshida, Tohru;Isaka, Naohide;Jain, Rakesh K.
通讯作者: Jain, Rakesh K.
SIX1 通过协调 TGF β 信号增加 VEGF-C 的表达来促进肿瘤淋巴管生成
DOI: 10.1158/0008-5472.can-13-3598
发表时间: 2014-10-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Liu, Dan;Li, Li;Gao, Qing-Lei
通讯作者: Gao, Qing-Lei
DOI: 10.1016/j.fct.2016.05.009
发表时间: 2016-08-01
影响因子: 4.3
作者:
Huang, Shu-Fang;Horng, Chi-Ting;Chen, Pei-Ni
通讯作者: Chen, Pei-Ni